☆ 4.7 Article

Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease

RHEUMATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Rheumatology

Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort

Bilal F. Samhouri et al.

Summary: This study investigated the incidence, risk factors, and outcomes of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) and assessed time trends. The study found that RA-ILD occurs in nearly 1 in 6 patients with RA within 20 years and is associated with shorter survival. However, the incidence of RA-ILD has not significantly changed in almost 60 years.

ARTHRITIS CARE & RESEARCH (2022)

Add to Collection

Article Rheumatology

Predictors of progression in rheumatoid arthritis-associated interstitial lung disease: A single-center retrospective study from China

Lei Liu et al.

Summary: This study aims to identify predictors of disease progression in early stages of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). The results suggest that high disease activity, definite usual interstitial pneumonia pattern, fibrosis score, and less use of cyclophosphamide at the onset of ILD may indicate the progression of ILD in RA patients.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)

Add to Collection

Article Rheumatology

The impact of disease severity measures on survival in US Veterans with rheumatoid arthritis-associated interstitial lung disease

Rebecca Brooks et al.

Summary: The severity of RA and ILD is associated with survival in patients with RA-ILD. Monitoring the systemic features of RA-ILD has prognostic value.

RHEUMATOLOGY (2022)

Add to Collection

Article Rheumatology

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Anna-Maria Hoffmann-Vold et al.

Summary: This study utilized data from the European Scleroderma Trials And Research (EUSTAR) database to analyze the disease course, progression patterns, and predictive factors for progressive interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD (SSc-ILD). The results showed that male sex, higher modified Rodnan skin score, and reflux/dysphagia symptoms were the strongest predictive factors for forced vital capacity (FVC) decline over a 5-year period in SSc-ILD patients.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

Vanessa L. Kronzer et al.

Summary: This study identified obesity, high CRP levels, poor functional status, and extensive smoking as novel risk factors for RA-ILD, which may be helpful for RA-ILD risk assessment and prevention. The overall predictive ability for RA-ILD remains modest.

JOURNAL OF RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis

Shinji Izuka et al.

Summary: This study retrospectively analyzed the clinical characteristics and risk factors of ILD-AE in 165 RA-ILD patients. The results showed a significant association between the UIP pattern and the occurrence of ILD-AE and mortality.

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients

Jeffrey A. Sparks et al.

Summary: This study investigated the prevalence, incidence, and cause-specific mortality of RA-associated interstitial lung disease (RA-ILD) among older US patients with RA. The results showed that RA-ILD was present or developed in nearly 5% of patients, and RA-ILD was associated with excess total, respiratory, and cancer mortality compared with RA without ILD.

RHEUMATOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department

Hye Jin Jang et al.

Summary: This study found that higher doses of corticosteroids can improve outcomes in patients with acute exacerbation of non-idiopathic pulmonary fibrosis (IPF) interstitial lung disease (ILD). However, this was not the case in patients with IPF.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Medicine, General & Internal

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody

Hiroyuki Kamiya et al.

Summary: The study aimed to investigate the relationship between anti-cyclic citrullinated peptide (CCP) antibody and rheumatoid arthritis-associated interstitial lung disease (RA-ILD). A total of 29 studies involving 10158 subjects were reviewed, showing that the presence and higher titres of anti-CCP antibody were significantly associated with an increased risk of RA-ILD. The quality of evidence was rated as low or very low, highlighting the need for further research in this area.

BMJ OPEN (2021)

Add to Collection

Article Rheumatology

Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis

Sisi Xie et al.

Summary: This meta-analysis found that patients who are positive for ACPA and RF have a higher risk of developing rheumatoid arthritis-related interstitial lung disease (RA-ILD), particularly emphasizing the need for closer monitoring of RA patients who are positive for ACPA.

CLINICAL RHEUMATOLOGY (2021)

Add to Collection

Review Respiratory System

Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management

Suha Kadura et al.

Summary: Rheumatoid arthritis (RA) is a systemic inflammatory disorder, with lung involvement being the most common extra-articular manifestation. RA-ILD is a leading cause of death in RA patients with significant morbidity and mortality. Rational clinical approaches for the diagnosis and management of RA-ILD are discussed, along with future directions for research in RA-associated lung disease.

EUROPEAN RESPIRATORY REVIEW (2021)

Add to Collection

Article Rheumatology

Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study

Clive A. Kelly et al.

Summary: The study showed that the prognosis of patients with RA-ILD has improved over a 25-year period, with an increase in all cause (respiratory) mortality compared to controls. Use of specific drugs like anti-TNF therapy may increase the risk of death, while rituximab or mycophenolate could lower mortality rates. Patients receiving rituximab as their first biologic had better survival rates compared to those receiving anti-TNF agents.

RHEUMATOLOGY (2021)

Add to Collection

Article Respiratory System

Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of US Veterans

Jake G. Natalini et al.

Summary: The study found that combined RF/ACPA seropositivity and higher individual autoantibody concentrations were strongly associated with prevalent RA-ILD, but not with incident RA-ILD. Patients with RF concentrations greater than 90 IU/ml were observed to be at higher risk of developing incident RA-ILD.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Add to Collection

Article Rheumatology

A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease

Luling Li et al.

CLINICAL RHEUMATOLOGY (2020)

Add to Collection

Article Respiratory System

The natural history of progressive fibrosing interstitial lung diseases

K.K. Brown et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection

Article Critical Care Medicine

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U Wells et al.

Lancet Respiratory Medicine (2020)

Add to Collection

Article Multidisciplinary Sciences

A prospective study of lung disease in a cohort of early rheumatoid arthritis patients

A. Robles-Perez et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Rheumatology

The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment

Ana C. Duarte et al.

RHEUMATOLOGY (2019)

Add to Collection

Article Rheumatology

Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study

Jeffrey A. Sparks et al.

ARTHRITIS & RHEUMATOLOGY (2019)

Add to Collection

Article Rheumatology

Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry

Sicong Huang et al.

CLINICAL RHEUMATOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Respiratory System

Predicting outcomes in rheumatoid arthritis related interstitial lung disease

Joseph Jacobt et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Add to Collection

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection

Article Rheumatology

Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis

Dam Kim et al.

RHEUMATOLOGY INTERNATIONAL (2017)

Add to Collection

Article Rheumatology

Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease

Jorge A. Zamora-Legoff et al.

ARTHRITIS & RHEUMATOLOGY (2017)

Add to Collection

Article Rheumatology

A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality

Charlotte Hyldgaard et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection

Article Respiratory System

Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease

Joshua J. Solomon et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Add to Collection

Article Critical Care Medicine

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers

Tracy J. Doyle et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Add to Collection

Article Rheumatology

Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling

Ada Man et al.

RHEUMATOLOGY (2015)

Add to Collection

Review Respiratory System

Predictors of mortality in rheumatoid arthritis-related interstitial lung disease

Deborah Assayag et al.

RESPIROLOGY (2014)

Add to Collection

Article Rheumatology

Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study

Clive A. Kelly et al.

RHEUMATOLOGY (2014)

Add to Collection

Article Critical Care Medicine

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis

Shunsuke Mori et al.

RESPIRATORY MEDICINE (2012)

Add to Collection

Article Critical Care Medicine

An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Add to Collection

Article Rheumatology

Pulmonary involvement in early rheumatoid arthritis patients

Hisham M. Habib et al.

CLINICAL RHEUMATOLOGY (2011)

Add to Collection

Article Psychology, Clinical

Group-Based Trajectory Modeling in Clinical Research

Daniel S. Nagin et al.

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 6 (2010)

Add to Collection

Article Rheumatology

Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis

Tim Bongartz et al.

ARTHRITIS AND RHEUMATISM (2010)

Add to Collection

Article Rheumatology

2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Daniel Aletaha et al.

ARTHRITIS AND RHEUMATISM (2010)

Add to Collection

Article Rheumatology

Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort

Gouri Koduri et al.

RHEUMATOLOGY (2010)

Add to Collection

Article Social Sciences, Mathematical Methods

Advances in group-based trajectory modeling and an SAS procedure for estimating them

Bobby L. Jones et al.

SOCIOLOGICAL METHODS & RESEARCH (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.